Fast-track to a solid dispersion formulation using multi-way analysis of complex interactions

Journal of Pharmaceutical Sciences

Volumn 102, Issue 3, 2013, Pages 904-914

  Wu, Jian X ^a   Den Berg, Frans Van ^b   Søgaard, Søren V ^a   Rantanen, Jukka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ANOVA; Design space; Factorial design; GEMANOVA; Image analysis; Multivariate analysis; PARAFAC; Quality by Design (QbD); Solid dispersion; X ray diffractometry

Indexed keywords

PIROXICAM;

ANALYSIS OF VARIANCE; ARTICLE; CHEMICAL INTERACTION; CRYSTALLIZATION; DISPERSION; GENERALIZED MULTIPLICATIVE ANALYSIS OF VARIANCE; IMAGE ANALYSIS; SOLID; X RAY POWDER DIFFRACTION;

EID: 84878162107     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23409     Document Type: Article

References (37)

1. Serajuddin ATM. 1999. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88(10):1058-1066.
2. Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50(1):47-60.
3. Newman A, Knipp G, Zografi G. 2012. Assessing the performance of amorphous solid dispersions. J Pharm Sci 101(4):1355-1377.
4. Van den Mooter G. 2012. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today 9(2):e79-e85.
5. Sertsou G, Butler J, Scott A, Hempenstall J, Rades T. 2002. Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation. Int J Pharm 245(1-2):99-108.
6. Konno H, Taylor LS. 2006. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 95(12):2692-2705.
7. Ingkatawornwong S, Kaewnopparat N, Tantishaiyakul V. 2001. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions. Pharmazie 56(3):227-230.
8. Van Eerdenbrugh B, Taylor LS. 2010. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. Mol Pharm 7(4):1328-1337.
9. Wu JX, Yang M, Berg Fvd, Pajander J, Rades T, Rantanen J. 2011. Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability. Eur J Pharm Sci 44(5):610-620.
10. Martin-Moe S, Lim FJ, Wong RL, Sreedhara A, Sundaram J, Sane SU. 2011. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design. J Pharm Sci 100(8):3031-3043.
11. Vogt FG, Kord AS. 2011. Development of quality-by-design analytical methods. J Pharm Sci 100(3):797-812.
12. Yu L. 2008. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharm Res 25(4):781-791.
13. Zacour BM, Drennen JK, Anderson CA. 2012. Development of a fluid bed granulation design space using critical quality attribute weighted tolerance intervals. J Pharm Sci 101(8):2917-2929.
14. ICH 2009. Harmonised Tripartite Guideline: Pharmaceutical Development Q8 (R2). Fed. Regist. 71 (98).
15. Hanrahan G, Lu K. 2006. Application of factorial and response surface methodology in modern experimental design and optimization. Crit Rev Anal Chem 36(3-4):141-151.
16. Smilde A, Bro R, Geladi P. 2004. Multi-way analysis: Applications in the chemical sciences. Chichester, England: John Wiley & Sons Ltd.
17. Naelapää K, Allesø M, Kristensen HG, Bro R, Rantanen J, Bertelsen P. 2009. Increasing process understanding by analyzing complex interactions in experimental data. J Pharm Sci 98(5):1852-1861.
18. Rathore AS. 2009. Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol 27(9):546-553.
19. Bro R. 1997. PARAFAC. Tutorial and applications. Chemom Intell Lab Syst 38(2):149-171.
20. Massart DL, Vandeginste BGM, Buydens LMC, Jong SD, Lewi PJ, Smeyers-Verbeke J. 1997. Handbook of chemometrics and qualimetrics-Part A, data handling in science and technology.Amsterdam, the Netherlands: Elsevier.
21. Bray JH, Maxwell SE, Eds. 1985. Multivariate analysis of variance. Newbury Park, California: Sage University Paper.
22. Leurgans S, Ross RT. 1992. Multilinear models: Applications in spectroscopy. Stat Sci 7(3):289-310.
23. Lebrun P, Krier F, Mantanus J, Grohganz H, Yang M, Rozet E, Boulanger B, Evrard B, Rantanen J, Hubert P. 2012. Design space approach in the optimization of the spray-drying process. Eur J Pharm Biopharm 80(1):226-234.
24. Riu J, Bro R. 2003. Jack-knife technique for outlier detection and estimation of standard errors in PARAFAC models. Chemom Intell Lab Syst 65(1):35-49.
25. Liland KH, Færgestad EM. 2009. Testing effects of experimental design factors using multi-way analysis. Chemom Intell Lab Syst 96(2):172-181.
26. Hayashi Y, Kikuchi S, Onuki Y, Takayama K. 2012. Reliability evaluation of nonlinear design space in pharmaceutical product development. J Pharm Sci 101(1):333-341.
27. Wu JX, Xia D, Berg Fvd, Amigo JM, Rades T, Yang M, Rantanen J. 2012. A novel image analysis methodology for online monitoring of nucleation and crystal growth during solid state phase transformations. Int J Pharm 433(1-2):60-70.
28. van Mispelaar VG, Tas AC, Smilde AK, Schoenmakers PJ, van Asten AC. 2003. Quantitative analysis of target components by comprehensive two-dimensional gas chromatography. J Chromatogr A 1019(1-2):15-29.
29. Berg Fvd, Tomasi G, Viereck N. 2005. Warping: Investigation of NMR pre-processing and correction. In Magnetic resonance in food science; Belton PS, Engelsen SB, Jakobsen HJ, Eds. London, UK: The Royal Society of Chemistry.
30. Bro R, Kjeldahl K, Smilde A, Kiers H. 2008. Cross-validation of component models: A critical look at current methods. Anal Bioanal Chem 390(5):1241-1251.
31. Wehrens R, Putter H, Buydens LMC. 2000. The bootstrap: A tutorial. Chemom Intell Lab Syst 54(1):35-52.
32. Vrecer F, Vrbinc M, Meden A. 2003. Characterization of piroxicam crystal modifications. Int J Pharm 256(1-2):3-15.
33. Sheth AR, Bates S, Muller FX, Grant DJW. 2004. Local structure in amorphous phases of piroxicam from powder X-ray diffractometry. Cryst Growth Des 5(2):571-578.
34. Law HG, Snyder CW, Hattie J, McDonald RP, Eds. 1984. Research methods for multimode data analysis. New York: Praeger.
35. Kjeldahl K, Bro R. 2010. Some common misunderstandings in chemometrics. J Chemom 24(7-8):558-564.
36. Bro R, Jakobsen M. 2002. Exploring complex interactions in designed data using GEMANOVA. Color changes in fresh beef during storage. J Chemom 16(6):294-304.
37. Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. 1996. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm 143(1):59-66.